EP3829551
Kristalskennt epinefrínmalónatsalt
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.7.2019EP published:
3.1.2024EP application number:
19845343.3
EP translation filed:
1.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
28.7.2039Expiry date:
28.7.2026Next due date:
31.7.2026
Title in English:
CRYSTALLINE EPINEPHRINE MALONATE SALTLanguage of the patent:
English
Timeline
Today
29.7.2019EP application
3.1.2024EP Publication
1.2.2024Translation submitted
15.3.2024Registration published
28.7.2026Expires
Owner
Name:
Biothea Pharma, Inc.Address:
2 Avery Street, Suite 21 E, Boston, Massachusetts 02111, US
Inventor
Name:
SOMMADOSSI, Jean-PierreAddress:
Boston, Massachusetts 02110, US
Name:
MOUSSA, AdelAddress:
Burlington, Massachusetts 01803, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862711936 PDate:
30.7.2018Country:
US
Number:
201862731442 PDate:
14.9.2018Country:
US
Classification
Categories:
C07C 55/08, C07C 215/60, A61K 31/00, A61K 31/137, A61K 47/12
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.7.2024
Expires: 28.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 29.7.2025
Expires: 28.7.2026
Payer: Árnason Faktor ehf.